In 2007, Bayer took over Schering AG and formed Bayer Schering Pharma. The acquisition of Schering was the largest take-over in Bayers history. The name was changed to Bayer Pharma in 2011. Bayer
Healthcare Pharmaceuticals is divided into two
business units – General
Medicine and Specialty Medicine. Womens
healthcare is an example of a General
Medicine business unit. Bayer Pharma produces the
birth control pills Yaz and Yasmin. Both pills use a newer type of
progesterone hormone called drospirenone in combination with estrogen. Yaz is advertised as a treatment for premenstrual dysphoric disorder and moderate acne. Other key products include the
cancer drug Nexavar, the
multiple sclerosis drug betaferon/betaseron and the blood-clotting drug, Kogenate. An example of a Specialty
Medicine Business Unit is Diagnostic Imaging. Contrast agents from this unit helps play a crucial role in precise and early diagnosis and the selection of optimal treatment. Diagnostic imaging techniques such as
computed tomography (CT),
magnetic resonance imaging (MRI) and ultrasound are used to make tissues and organs visible in their natural position inside the body along with contrast. Work is also focused on the development of tracers for positron emission tomography (PET). The PET tracer florbetaben F18 in Bayers pipeline makes it possible to recognize beta amyloid, one of the pathological hallmarks of
Alzheimers disease, with high accuracy very early on and while the patient is still alive.
Last Updated on: Nov 27, 2024